These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 136659)

  • 1. Alterations in brain muscarinic cholinergic receptor binding and choline acetyltransferase activity in Huntington's disease.
    Wastek GJ; Johnson PC; Stern LZ; Yamamura HI
    Proc West Pharmacol Soc; 1976; 19():170-1. PubMed ID: 136659
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington's disease.
    Wastek GJ; Yamamura HI
    Mol Pharmacol; 1978 Sep; 14(5):768-80. PubMed ID: 152407
    [No Abstract]   [Full Text] [Related]  

  • 3. Huntington's disease: regional alteration in muscarinic cholinergic receptor binding in human brain.
    Wastek GJ; Stern LZ; Johnson PC; Yamamura HI
    Life Sci; 1976 Oct; 19(7):1033-9. PubMed ID: 136582
    [No Abstract]   [Full Text] [Related]  

  • 4. Plasma choline and cholinergic mechanisms in the brain. Methods, function, and rôle in Huntington's chorea.
    Eckernäs SA
    Acta Physiol Scand Suppl; 1977; 449():1-62. PubMed ID: 143869
    [No Abstract]   [Full Text] [Related]  

  • 5. Huntington's chorea. Changes in neurotransmitter receptors in the brain.
    Enna SJ; Bird ED; Bennett JP; Bylund DB; Yamamura HI; Iversen LL; Snyder SH
    N Engl J Med; 1976 Jun; 294(24):1305-9. PubMed ID: 4733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of brain neurotransmitter receptor binding in Huntington's chorea.
    Enna SJ; Bennett JP; Bylund DB; Snyder SH; Bird ED; Iversen LL
    Brain Res; 1976 Nov; 116(3):531-7. PubMed ID: 10053
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain muscarinic cholinergic receptors in Huntington's disease.
    Lange KW; Javoy-Agid F; Agid Y; Jenner P; Marsden CD
    J Neurol; 1992 Feb; 239(2):103-4. PubMed ID: 1532417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the neurochemistry of Huntington's disease.
    Wastek GJ; Stern LZ; Yamamura HI
    Ariz Med; 1977 Aug; 34(8):547-8. PubMed ID: 143259
    [No Abstract]   [Full Text] [Related]  

  • 9. Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.
    Aquilonius SM; Eckernås SA; Sundwall A
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):669-77. PubMed ID: 125784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Circadian changes of acetylcholine, choline acetyltransferase, acetylcholinesterase and muscarinic receptors in mouse brain].
    Pan SY
    Zhongguo Yao Li Xue Bao; 1991 Mar; 12(2):148-51. PubMed ID: 1776479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
    Rossor M; Emson P; Dawbarn D; Dockray G; Mountjoy C; Roth M
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():259-77. PubMed ID: 2425405
    [No Abstract]   [Full Text] [Related]  

  • 13. m2 muscarinic acetylcholine receptor-immunoreactive neurons are not reduced within the nucleus basalis in Alzheimer's disease: relationship with cholinergic and galaninergic perikarya.
    Mufson EJ; Jaffar S; Levey AI
    J Comp Neurol; 1998 Mar; 392(3):313-29. PubMed ID: 9511920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia.
    Friedman E; Gianutsos G; Kuster J
    J Pharmacol Exp Ther; 1983 Jul; 226(1):7-12. PubMed ID: 6864552
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of reserpine on choline acetyltransferase and high affinity choline uptake in the rat brain [proceedings].
    Burgess EJ; Prince AK; Brownlee G
    Br J Pharmacol; 1977 Jun; 60(2):301P-302P. PubMed ID: 880468
    [No Abstract]   [Full Text] [Related]  

  • 16. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic receptor sites in cerebral blood vessels.
    Estrada C; Krause DN
    J Pharmacol Exp Ther; 1982 Apr; 221(1):85-90. PubMed ID: 7062294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in dopaminergic receptors in Huntington's disease.
    Reisine TD; Fields JZ; Stern LZ; Johnson PC; Bird ED; Yamamura HI
    Life Sci; 1977 Oct; 21(8):1123-8. PubMed ID: 144230
    [No Abstract]   [Full Text] [Related]  

  • 19. Nicotinic and muscarinic cholinergic receptors in Alzheimer's disease and related disorders.
    Whitehouse PJ; Kellar KJ
    J Neural Transm Suppl; 1987; 24():175-82. PubMed ID: 2960781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choline acetyltransferase in the neural plexus of the main artery of cat's brain].
    Motavkin PA; Vlasov GS; Lemakin AV; Mukhina GM
    Arkh Anat Gistol Embriol; 1977; 72(1):40-3. PubMed ID: 869719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.